Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes
Open Access
- 19 November 2020
- journal article
- research article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 8 (2) , e001851
Abstract
Introduction To investigate the risk factors for the death in patients with COVID-19 with type 2 diabetes mellitus (T2DM). Research design and methods We retrospectively enrolled inpatients with COVID-19 from Wuhan Jinyintan Hospital (Wuhan, China) between December 25, 2019, and March 3, 2020. The epidemiological and clinical data were compared between non-T2DM and T2DM or between survivors and non-survivors. Univariable and multivariable Cox regression analyses were used to explore the effect of T2DM and complications on in-hospital death. Results A total of 1105 inpatients with COVID-19, 967 subjects with without T2DM (n=522 male, 54.0%) and 138 subjects with pre-existing T2DM (n=82 male, 59.4%) were included for baseline characteristics analyses. The complications were also markedly increased in patients with pre-existing T2DM, including acute respiratory distress syndrome (ARDS) (48.6% vs 32.3%, pConclusions Coagulopathy was a major extrapulmonary risk factor for death in inpatients with COVID-19 with T2DM rather than ACI and AKI, which were well associated with mortality in inpatients with COVID-19 without T2DM.Keywords
Funding Information
- Shanghai Top-Priority Clinical Key Disciplines Construction Project (2017ZZ02013)
- Prevention and Treatment of Infection in Novel Coronavirus Pneumonia Patients from the Science and Technology Committee of Shanghai Municipality (20411950402)
- Shanghai Municipal Key Clinical Specialty (shslczdzk02201)
- the Sub-specialist project of Qingpu Branch of Zhongshan Hospital, Fudan University (YZK 2019-04)
- the National Natural Science Foundation of China (NSFC) for Novel Coronavirus Pneumonia (82041003)
- the Shanghai key discipline of medicine (ZK2019B07 SZ2019-1)
This publication has 27 references indexed in Scilit:
- Coagulatory Defects in Type-1 and Type-2 DiabetesInternational Journal of Molecular Sciences, 2019
- Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infectionJCI Insight, 2019
- Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot studyAnnals of Intensive Care, 2019
- Le diabète, une pathologie prothrombotiqueAnnales de Cardiologie et d'Angéiologie, 2017
- Coagulation and sepsisThrombosis Research, 2017
- Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host Response*Critical Care Medicine, 2016
- Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive studyThe Lancet Infectious Diseases, 2013
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysisBMJ, 2003
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988